The Autoridade Nacional Reguladora de Medicamentos de Moçambique (ANARME) has achieved Maturity Level 3 (ML3) for regulating medicines and imported vaccines under WHO’s global classification of national regulatory authorities.
In Mozambique, the 2022–2023 Demographic and Health Survey places the under-five mortality rate at 60 deaths per 1,000 live births.